Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.
Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, La Forge R, Daniels SR, Wilson DP, Morris PB, Wild RA, Grundy SM, Daviglus M, Ferdinand KC, Vijayaraghavan K, Deedwania PC, Aberg JA, Liao KP, McKenney JM, Ross JL, Braun LT, Ito MK, Bays HE, Brown WV, Underberg JA; NLA Expert Panel. Jacobson TA, et al. Among authors: braun lt. J Clin Lipidol. 2015 Nov-Dec;9(6 Suppl):S1-122.e1. doi: 10.1016/j.jacl.2015.09.002. Epub 2015 Sep 18. J Clin Lipidol. 2015. PMID: 26699442 Free article.
Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context.
Al Rifai M, Blumenthal RS, Stone NJ, Schofield RS, Orringer CE, Michos ED, Heidenreich PA, Braun L, Birtcher KK, Smith SC, Nambi V, Grundy S, Virani SS. Al Rifai M, et al. Prog Cardiovasc Dis. 2021 Sep-Oct;68:2-6. doi: 10.1016/j.pcad.2021.08.001. Epub 2021 Aug 8. Prog Cardiovasc Dis. 2021. PMID: 34371083 Review.
Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.
Davidson MH, Ballantyne CM, Jacobson TA, Bittner VA, Braun LT, Brown AS, Brown WV, Cromwell WC, Goldberg RB, McKenney JM, Remaley AT, Sniderman AD, Toth PP, Tsimikas S, Ziajka PE, Maki KC, Dicklin MR. Davidson MH, et al. Among authors: braun lt. J Clin Lipidol. 2011 Sep-Oct;5(5):338-67. doi: 10.1016/j.jacl.2011.07.005. J Clin Lipidol. 2011. PMID: 21981835
Achieving adherence to lipid-lowering regimens.
Brown WV, Jacobson TA, Braun LT. Brown WV, et al. Among authors: braun lt. J Clin Lipidol. 2013 Jan-Feb;7(1):4-13. doi: 10.1016/j.jacl.2012.11.004. Epub 2012 Dec 21. J Clin Lipidol. 2013. PMID: 23351577 No abstract available.
High-Intensity Statins Benefit High-Risk Patients: Why and How to Do Better.
Grundy SM, Stone NJ, Blumenthal RS, Braun LT, Heidenreich PA, Lloyd-Jones D, Orringer CE, Saseen JJ, Smith SC Jr, Sperling LS, Virani SS. Grundy SM, et al. Among authors: braun lt. Mayo Clin Proc. 2021 Oct;96(10):2660-2670. doi: 10.1016/j.mayocp.2021.02.032. Epub 2021 Sep 14. Mayo Clin Proc. 2021. PMID: 34531060 Review.
Therapeutic Inertia in Cardiovascular Disease Prevention: Time to Move the Bar.
Dixon DL, Sharma G, Sandesara PB, Yang E, Braun LT, Mensah GA, Sperling LS, Deedwania PC, Virani SS. Dixon DL, et al. Among authors: braun lt. J Am Coll Cardiol. 2019 Oct 1;74(13):1728-1731. doi: 10.1016/j.jacc.2019.08.014. J Am Coll Cardiol. 2019. PMID: 31558257 Free article. Review. No abstract available.
JCL Roundtable. The lipidology team.
Williams L, Braun LT, Saseen JJ, Guyton JR. Williams L, et al. Among authors: braun lt. J Clin Lipidol. 2022 Jan-Feb;16(1):3-12. doi: 10.1016/j.jacl.2022.01.003. J Clin Lipidol. 2022. PMID: 35151418
136 results